CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-01-03 | DAVIS STEPHEN Chief Operating Officer | Grant or award · Stock Option (right to buy) | +1,066,667 | 1,066,667 | ||
| 2013-11-20 | TANG KEVIN C Director | Grant or award | +17,500,000 | $0.40 | $7.0M | 81,713,600 |
| 2013-11-20 | Quart Barry D Chief Executive Officer | Purchase | +1,000,000 | $0.40 | $400K | 1,037,100 |
| 2013-07-18 | Whelan John CFO | Exercise or conversion | +254,088 | $0.26 | $66K | 254,088 |
| 2013-07-18 | Whelan John CFO | Exercise or conversion · Incentive Stock Option (right to buy) | −254,088 | 393,366 | ||
| 2013-05-01 | Rosen Robert President | Grant or award · Stock Option (right to buy) | +22,500,000 | 22,500,000 | ||
| 2013-05-01 | Quart Barry D Chief Executive Officer | Grant or award · Stock Option (right to buy) | +22,500,000 | 22,500,000 | ||
| 2013-05-01 | DAVIS STEPHEN Chief Operating Officer | Grant or award · Stock Option (right to buy) | +11,000,000 | 11,000,000 | ||
| 2013-05-01 | Gelder Mark S. MD SVP & Chief Medical Officer | Grant or award · Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2013-02-08 | ADAM MICHAEL A Chief Operating Officer | Grant or award · Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2013-02-08 | Rosen Robert SVP & Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2013-02-08 | Gelder Mark S. MD SVP & Chief Medical Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2013-02-08 | Whelan John President, CEO and CFO | Grant or award · Stock Option (right to buy) | +1,750,000 | 1,750,000 | ||
| 2013-01-01 | SPCH, LLC 10% owner | Other disposition | −36,190,476 | 0 | ||
| 2012-10-15 | Rosen Robert SVP & Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +10,000,000 | 10,000,000 | ||
| 2012-07-25 | SPCH, LLLP 10% owner | Purchase | +38,095,238 | $0.53 | $20.0M | 38,095,238 |
| 2012-07-25 | TANG KEVIN C Director | Grant or award | +9,523,810 | $0.53 | $5.0M | 69,960,316 |
| 2012-05-29 | TANG KEVIN C Director | Grant or award · Non-Qualified Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2012-05-29 | GODDARD PAUL Director | Grant or award · Non-Qualified Stock Option | +500,000 | 500,000 | ||
| 2012-05-29 | TURNBULL GREG Director | Grant or award · Non-Qualified Stock Option | +500,000 | 500,000 |
Page 40 of 45 · 881 trades